Today’s advice comes from Merck CEO Kenneth Frazier’s interview with The Wall Street Journal:“I’m trying to run the company in a way that I can satisfy the short- and intermediate-term needs of investors without sacrificing really what we’re about.”
Frazier, who made a decision to maintain the drug maker’s spending on research and development despite angering investors, says he’s willing to take a “few brickbats thrown in my direction.”
“Science and innovation are in the DNA of the company,” he says. “The science will lead us to another big breakthrough.”
Want your business advice featured in Instant MBA? Submit your tips to [email protected]. Be sure to include your name, your job title, and a photo of yourself in your email.
NOW WATCH: Ideas videos
Business Insider Emails & Alerts
Site highlights each day to your inbox.